Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Dual targeting of MEK and PI3K effectively controls the proliferation of human EGFR-TKI resistant non-small cell lung carcinoma cell lines with different genetic backgrounds

Fig. 2

Effect of MEK162/BKM120 combination therapy on H1975, H460, and A549 cell apoptosis. H1975 (A), H460 (B), and A549 (C) cells were treated with 1 µM MEK162 or 5 µM BKM120 alone or their combination for 48 h. Control cells were treated with 0.05% DMSO. Cells were simultaneously stained with annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI), and the apoptosis rates were assessed by flow cytometry. Cells positive for annexin V-FITC and negative for PI were in early apoptosis

Back to article page